Marango Jotin 4
4 · Ikena Oncology, Inc. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Marango Jotin
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-03+105,000→ 105,000 totalExercise: $2.62Exp: 2033-01-03→ Common Stock (105,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to this option shall vest and become exercisable on January 1, 2024, with the remainder vesting in 36 substantially equal monthly installments thereafter.